Inflammation-Driven Downregulation of CYP2E1 Is Associated with Attenuated Diethylnitrosamine (DEN)-Induced Hepatocarcinogenesis
Cells · 19.03.2026 · 15 (6) · 546
DOI: 10.3390/cells15060546 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 19.03.2026. Verfasst von Yoshihiro Tsuchiya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Health, Faculty of Human Life Studies, Hiroshima Jogakuin University, Hiroshima 732-0063, Japan. Hauptthemen laut MEDLINE: Inflammation, Cytochrome P-450 CYP2E1, Carcinogenesis, Down-Regulation. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, JSPS KAKENHI, Hiroshima Jogakuin University.
Abstract (Originalsprache)
Inflammation is widely viewed as a driver of hepatocellular carcinoma (HCC), yet inflammatory signaling also reshapes hepatic xenobiotic metabolism. Here, we established transgenic (Tg) IKKβΔhep mice (Tg-IKKβΔhep), which combine hepatocyte-specific IKKβ deletion with liver expression of a nuclear, kinase-inactive IKKβ mutant (NLS-IKKβKN). Tg-IKKβΔhep mice developed spontaneous chronic hepatitis and progressive fibrosis but were strikingly resistant to diethylnitrosamine (DEN)-induced hepatocarcinogenesis, with markedly reduced tumor multiplicity and total tumor burden. Despite persistent inflammatory injury, DEN-triggered oxidative DNA damage and p53 activation were markedly attenuated, compatible with reduced tumor initiation. Transcriptomic and biochemical analyses revealed broad repression of xenobiotic-metabolizing cytochrome P450 genes, including the pericentral enzyme CYP2E1, accompanied by reduced CYP2E1 protein abundance. This was associated with impaired HNF4α–PXR–CAR transcriptional output and reduced HNF4α occupancy at target promoters. Acute TNFα or IL-1β exposure recapitulated this repression, in part through reduced PGC-1α expression and decreased RNA polymerase II recruitment to target promoters. In parallel, pericentral xenobiotic metabolism was blunted, a change that could plausibly diminish DEN bioactivation and genotoxic stress. Together, these findings support a “metabolic gatekeeping” model in which chronic inflammation can constrain chemical hepatocarcinogenesis by attenuating carcinogen-metabolizing capacity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Health, Faculty of Human Life Studies, Hiroshima Jogakuin University, Hiroshima 732-0063, Japan.
- Department of Molecular Medical Science, Graduate School of Biomedical Science, Hiroshima University, Hiroshima 734-8553, Japan.
- Natural Science Center for Basic Research and Development, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan.
- Graduate School of Frontier Sciences, The University of Tokyo, Chiba 277-8562, Japan.
- Department of Gastroenterology, School of Medicine, Yokohama City University, Yokohama 236-0004, Japan.
ORCID-Profile: Yusuke Sotomaru, Shin Maeda
Förderung
- Japan Society for the Promotion of Science
- JSPS KAKENHI
- Hiroshima Jogakuin University
Zitieren
APA
Tsuchiya, Y., Sotomaru, Y., Kanai, A., Maeda, S., & Kamata, H. (2026). Inflammation-Driven Downregulation of CYP2E1 Is Associated with Attenuated Diethylnitrosamine (DEN)-Induced Hepatocarcinogenesis. Cells, 15(6), 546. https://doi.org/10.3390/cells15060546
Vancouver
Tsuchiya Y, Sotomaru Y, Kanai A, Maeda S, Kamata H. Inflammation-Driven Downregulation of CYP2E1 Is Associated with Attenuated Diethylnitrosamine (DEN)-Induced Hepatocarcinogenesis. Cells. 2026;15(6):546. doi:10.3390/cells15060546
BibTeX
@article{Tsuchiya2026,
author = {Tsuchiya, Yoshihiro and Sotomaru, Yusuke and Kanai, Akinori and Maeda, Shin and Kamata, Hideaki},
title = {Inflammation-Driven Downregulation of CYP2E1 Is Associated with Attenuated Diethylnitrosamine (DEN)-Induced Hepatocarcinogenesis},
journal = {Cells},
year = {2026},
volume = {15},
number = {6},
pages = {546},
doi = {10.3390/cells15060546}
}
EUVIMED